...
首页> 外文期刊>Drug testing and analysis >Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology
【24h】

Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology

机译:验证尿液中合成卡西酮的唯一市售免疫测定方法的有效性:Randox滥用药物V Biochip Array Technology

获取原文
获取原文并翻译 | 示例
           

摘要

Deterrence of synthetic cathinone abuse is hampered by the lack of a high-throughput immunoassay screen. The Randox Drugs of Abuse V (DOA-V) Biochip Array Technology contains two synthetic cathinone antibodies: Bath Salt I (BSI) targets mephedrone/methcathinone and Bath Salt II (BSII) targets 3',4'-methylenedioxypyrovalerone (MDPV)/3',4'-methylenedioxy-α-pyrrolidinobutiophenone (MDPBP). We evaluated DOA-V synthetic cathinones performance and conducted a full validation on the original assay with calibrators reconstituted in water, and the new assay with calibrators prepared in lyophilized urine; both utilized the same antibodies and were run on the fully automated Evidence? Analyzer. We screened 20 017 authentic military urine specimens and confirmed positives by liquid chromatography-tandem mass spectrometry (LC-MS/MS) for 28 synthetic cathinones. Limits of detection (LOD) for the original and new assays were 0.35 and 0.18 (BSI), and 8.5 and 9.2 μg/L (BSII), respectively. Linearity was acceptable (R20.98); however, a large negative bias was observed with in-house prepared calibrators. Intra-assay imprecision was 20% BSI-II, while inter-assay imprecision was 18-42% BSI and 22% BSII. Precision was acceptable for Randox controls. Cross-reactivities of many additional synthetic cathinones were determined. Authentic drug-free negative urine pH 4 produced false positive results for BSI (6.3 μg/L) and BSII (473 μg/L). Oxidizing agents reduced BSI and increased BSII results. Sensitivity, specificity, and efficiency of 100%, 52.1%, and 53.0% were obtained at manufacturer's proposed cut-offs (BSI 5 μg/L, BSII 30 μg/L). Performance improved if cut-off concentrations increased (BSI 7.5 μg/L, BSII 40 μg/L); however, there were limited confirmed positive specimens. Currently, this is the first and only fully validated immunoassay for preliminary detection of synthetic cathinones in urine. Published 2014. This article is a U.S. Government work and is in the public domain in the USA.
机译:缺乏高通量的免疫分析筛网阻碍了合成卡西酮滥用的威慑。 Randox药物滥用V(DOA-V)生物芯片阵列技术包含两种合成的卡西酮抗体:沐浴盐I(BSI)靶向甲氧麻黄酮/甲卡西酮,沐浴盐II(BSII)靶向3',4'-亚甲基二氧基吡咯烷酮(MDPV)/ 3 ',4'-亚甲基二氧基-α-吡咯烷基丁二酮(MDPBP)。我们评估了DOA-V合成Cathinones的性能,并使用水配制的校准物对原始测定法进行了全面验证,并使用冻干尿液制备的校准物对新测定法进行了全面验证。两者都使用相同的抗体,并在全自动证据上运行?分析仪。我们筛选了20 017个真实的军用尿液标本,并通过液相色谱-串联质谱(LC-MS / MS)确认了28种合成卡西酮的阳性。原始测定和新测定的检出限(LOD)分别为0.35和0.18(BSI),以及8.5和9.2μg/ L(BSII)。线性是可以接受的(R2> 0.98);但是,使用内部准备的校准器会观察到较大的负偏差。批内不准确度为<20%BSI-II,批间不准确度为18-42%BSI和<22%BSII。 Randox控件的精度是可以接受的。确定了许多其他合成Cathinones的交叉反应性。对BSI(6.3μg/ L)和BSII(473μg/ L)的真实无毒尿液pH <4产生假阳性结果。氧化剂可降低BSI并提高BSII结果。在制造商建议的临界值(BSI 5μg/ L,BSII 30μg/ L)下获得了100%,52.1%和53.0%的灵敏度,特异性和效率。如果截止浓度增加(BSI 7.5μg/ L,BSII 40μg/ L),性能会提高;但是,确诊的阳性标本有限。目前,这是第一个也是唯一一个经过完全验证的免疫分析方法,可用于尿液中合成卡西酮的初步检测。 2014年出版。本文是美国政府的工作,在美国属于公共领域。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号